SPEAKER NAME /
Joseph Saseen, PharmD, CLS
Time of Talk
This webcast will review several new nonstatin therapies that have been proven to reduce cardiovascular events, when added to statin therapy.
This enduring material activity, The Evolving Role of Nonstatin Medication in the Management of Hypercholesterolemia, has been reviewed and is acceptable for up to 1.0 prescribed credits by the American Academy of Family Physicians. Term of approval begins October 12, 2020. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity.